ALXO vs TOST · $207.2M cap vs P/E 161, rev $3.54B
Alx Oncology Holdings (ALXO) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
ALXO does not have a complete income-statement cache yet.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
ALXO currently screens at market cap $207.2M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the ALXO and TOST stock pages for the full models.
Not investment advice.